CA2083507A1 - Nicotinylalanine as a therapeutic agent acting on the central nervous system - Google Patents

Nicotinylalanine as a therapeutic agent acting on the central nervous system

Info

Publication number
CA2083507A1
CA2083507A1 CA002083507A CA2083507A CA2083507A1 CA 2083507 A1 CA2083507 A1 CA 2083507A1 CA 002083507 A CA002083507 A CA 002083507A CA 2083507 A CA2083507 A CA 2083507A CA 2083507 A1 CA2083507 A1 CA 2083507A1
Authority
CA
Canada
Prior art keywords
nicotinylalanine
acid
nervous system
central nervous
therapeutic agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002083507A
Other languages
English (en)
French (fr)
Inventor
Roberto Pellicciari
Flavio Moroni
Trevor W. Stone
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fidia SpA
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2083507A1 publication Critical patent/CA2083507A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
CA002083507A 1990-05-24 1991-05-21 Nicotinylalanine as a therapeutic agent acting on the central nervous system Abandoned CA2083507A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT02041890A IT1248486B (it) 1990-05-24 1990-05-24 Agente terapeutico ad attivita' sul sistema nervoso centrale
IT20418A/90 1990-05-24

Publications (1)

Publication Number Publication Date
CA2083507A1 true CA2083507A1 (en) 1991-11-25

Family

ID=11166634

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002083507A Abandoned CA2083507A1 (en) 1990-05-24 1991-05-21 Nicotinylalanine as a therapeutic agent acting on the central nervous system

Country Status (8)

Country Link
EP (1) EP0532545A1 (en])
JP (1) JPH05507086A (en])
AU (1) AU7883291A (en])
BR (1) BR9106500A (en])
CA (1) CA2083507A1 (en])
HU (1) HUT64695A (en])
IT (1) IT1248486B (en])
WO (1) WO1991017750A1 (en])

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0684238A3 (en) * 1994-04-27 1997-01-15 Hoffmann La Roche Process for the preparation of dicarboxamides.
US5536867A (en) * 1994-04-27 1996-07-16 Hoffmann-La Roche Inc. Process for the manufacture of dicarboxamides
AU707084B2 (en) * 1995-03-14 1999-07-01 Edward G. Shaskan Compositions comprising nicotynylalanine and an inhibitor of glycine conjugation or vitamin B6
RU2742765C1 (ru) * 2017-09-28 2021-02-10 ЭлДжи КЕМ, ЛТД. Способ получения промежуточного соединения для синтеза лекарственного средства

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3649649A (en) * 1967-07-10 1972-03-14 Nisso Kako Co Ltd Fluoran derivatives and preparation thereof
FR1596106A (en]) * 1968-12-13 1970-06-15
US4065566A (en) * 1975-04-17 1977-12-27 Interx Research Corporation N-Nicotinoyl-3,4-dinicotinoyloxy-L-phenylalanine and derivatives pharmaceutical compositions and methods containing same

Also Published As

Publication number Publication date
BR9106500A (pt) 1993-05-25
HU9203634D0 (en) 1993-03-29
AU7883291A (en) 1991-12-10
JPH05507086A (ja) 1993-10-14
IT1248486B (it) 1995-01-19
IT9020418A0 (en]) 1990-05-24
IT9020418A1 (it) 1991-11-24
EP0532545A1 (en) 1993-03-24
HUT64695A (en) 1994-02-28
WO1991017750A1 (en) 1991-11-28

Similar Documents

Publication Publication Date Title
US4153725A (en) Relieving angiotension related hypertension with carboxyalkylacylamino acids
CA1328658C (en) 3-indolepyruvic acid derivatives and pharmaceutical use thereof
CA1136549A (en) Combination of thienamycin-type antibiotics with dipeptidase inhibitors
RU2128160C1 (ru) Трометаминная соль (+)-(s)-2-(3-бензоилфенил)пропионовой кислоты, способ ее получения, фармацевтическая композиция
CA1217426A (en) Combination of 2-substituted penems with dipeptidase inhibitors
WO1992009560A1 (en) Gaba and l-glutamic acid analogs for antiseizure treatment
US4206232A (en) Relieving hypertension with carboxyalkylacylamino acids
US5147868A (en) Thienamycin renal peptidase inhibitors
US4551471A (en) Use of 3-indolepyruvic acid for increasing serotonin
CN111635309B (zh) 一种新型解热镇痛药物及其制备方法和用途
FR2934267A1 (fr) Derives aminophosphiniques utiles dans le traitement de la douleur
IE813104L (en) Method and compounds for treating inflammatory bowel¹disease
EP0663899B1 (en) Substituted kynurenines, a process for their preparation, and use as medicaments
US5019596A (en) Pharmaceutical compositions having therapeutical activity based on mercaptoethansulphonic acid
EP0110224A2 (de) Benzoylthioverbindungen, ihre Herstellung und Verwendung als Arzneimittel
IE49182B1 (en) Z-2-acylamino-3-monosubstituted propenic acids and their esters and salts and processes for preparing them
CA2083507A1 (en) Nicotinylalanine as a therapeutic agent acting on the central nervous system
US4228184A (en) Carboxyalkylacylamino acids
EP1165089A1 (fr) Utilisation de la tianeptine pour l'obtention de medicaments destines au traitement des pathologies de la neurodegenerescence
JPH08245658A (ja) ホスホノ酢酸誘導体および変形性関節疾患を治療するためのその使用
EP0066518B1 (en) Compounds and methods for treating depression
US4207337A (en) Relieving hypertension with carboxyalkylacylamino acids
US4271195A (en) Certain N-(β-phenyl-β-hydroxyethylamino)propiophenones as lipolysis promoters
US4207342A (en) Relieving hypertension with carboxyalkylacylamino acids
US4207336A (en) Relieving hypertension with carboxyalkylacylamino acids

Legal Events

Date Code Title Description
FZDE Discontinued